News & Updates

Show Multimedia Only

Perioperative adebrelimab plus chemo: A new Tx option for resectable NSCLC?

12 May 2026 by

Perioperative adebrelimab plus chemotherapy improves event-free survival (EFS) and major pathological response (MPR) in individuals with resectable stage II/III non-small cell lung cancer (NSCLC) in an interim analysis.

Perioperative adebrelimab plus chemo: A new Tx option for resectable NSCLC?

12 May 2026

Combination of factors influence childhood food allergy risk

12 May 2026

A combination of early allergic conditions, delayed allergen introduction, genetics, antibiotic exposure, demographic factors, and birth-related variables factor in the development of food allergy in children, according to a meta-analysis.

Combination of factors influence childhood food allergy risk

12 May 2026

High-dose influenza vaccination reduces hospitalizations in older adults

12 May 2026 by

High-dose influenza vaccination is associated with a reduced risk of hospitalization for pneumonia or influenza in older adults, regardless of immunosuppression status, according to a prespecified pooled analysis of the FLUNITY-HD study presented at ESCMID Global 2026.

High-dose influenza vaccination reduces hospitalizations in older adults

12 May 2026

High remission rates in FLT3-ITD AML with quizartinib/omacetaxine combo

12 May 2026 by

Researchers from the University of Hong Kong found that therapy with the synergistic combination of quizartinib and omacetaxine mepesuccinate (QUIZOM) in acute myeloid leukaemia (AML) patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutations produced high rates of composite complete remission (CRc), allowing more AML patients to be bridged to allogeneic haematopoietic stem cell transplantation (HSCT).

High remission rates in FLT3-ITD AML with quizartinib/omacetaxine combo

12 May 2026

Nitrofurantoin prevails in antibiotic showdown for uncomplicated UTI in women

11 May 2026 by

Nitrofurantoin performs better than single-dose fosfomycin in the treatment of uncomplicated urinary tract infections (UTIs) in women in the primary care setting, according to the SCOUT trial.

Nitrofurantoin prevails in antibiotic showdown for uncomplicated UTI in women

11 May 2026

Cancer patients at risk of heart disease death after surgery

11 May 2026

Patients who underwent primary cancer site surgery are at greater risk of death from heart disease than the general population, reports a US study.

Cancer patients at risk of heart disease death after surgery

11 May 2026

CtDNA testing predicts recurrence, enables personalized management in MIBC

11 May 2026 by

Circulating tumour DNA (ctDNA) testing after neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) may inform patients with muscle-invasive bladder cancer (MIBC) of their risk for recurrence and allows personalized postoperative management in MIBC, results of the TOMBOLA trial have shown.

CtDNA testing predicts recurrence, enables personalized management in MIBC

11 May 2026

Immunotherapy improves survival in ES-SCLC in first-line setting

11 May 2026

First-line treatment with immune checkpoint inhibitors (ICIs) is safe and effective in patients with extended stage (ES) small-cell lung cancer (SCLC), but its use as second-line agent is not recommended, according to a study.

Immunotherapy improves survival in ES-SCLC in first-line setting

11 May 2026

Tebentafusp a ray of hope in rare eye cancer

11 May 2026 by

The 5-year data from the phase III IMCgp100-202 study demonstrate durable, long-term overall survival (OS) benefit with the novel agent tebentafusp—a first-in-class, bispecific, soluble T-cell receptor (TCR) therapeutic—in individuals with previously untreated metastatic uveal melanoma (UM).

Tebentafusp a ray of hope in rare eye cancer

11 May 2026

Depression common during the peripartum period

11 May 2026

Major depressive disorder is prevalent during the entire peripartum period, with the highest prevalence observed 2 weeks following childbirth, as shown in a study.

Depression common during the peripartum period

11 May 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Perioperative adebrelimab plus chemo: A new Tx option for resectable NSCLC?

Perioperative adebrelimab plus chemo: A new Tx option for resectable NSCLC?

Combination of factors influence childhood food allergy risk

Combination of factors influence childhood food allergy risk

High-dose influenza vaccination reduces hospitalizations in older adults

High-dose influenza vaccination reduces hospitalizations in older adults

High remission rates in FLT3-ITD AML with quizartinib/omacetaxine combo

High remission rates in FLT3-ITD AML with quizartinib/omacetaxine combo

Nitrofurantoin prevails in antibiotic showdown for uncomplicated UTI in women

Nitrofurantoin prevails in antibiotic showdown for uncomplicated UTI in women

Cancer patients at risk of heart disease death after surgery

Cancer patients at risk of heart disease death after surgery

CtDNA testing predicts recurrence, enables personalized management in MIBC

CtDNA testing predicts recurrence, enables personalized management in MIBC

Immunotherapy improves survival in ES-SCLC in first-line setting

Immunotherapy improves survival in ES-SCLC in first-line setting

Tebentafusp a ray of hope in rare eye cancer

Tebentafusp a ray of hope in rare eye cancer

Depression common during the peripartum period

Depression common during the peripartum period